Woodward patent expiration
1. Avandia patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5741803 | WOODWARD | Substituted thiazolidinedionle derivatives |
Apr, 2015
(9 years ago) | |
|
US5741803 (Pediatric) | WOODWARD | Substituted thiazolidinedionle derivatives |
Oct, 2015
(8 years ago) | |
| US6288095 | WOODWARD | Compounds |
Feb, 2017
(7 years ago) | |
|
US6288095 (Pediatric) | WOODWARD | Compounds |
Aug, 2017
(6 years ago) | |
| US7358366 | WOODWARD | Thiazolidinedione derivative and its use as antidiabetic |
Apr, 2020
(4 years ago) | |
|
US7358366 (Pediatric) | WOODWARD | Thiazolidinedione derivative and its use as antidiabetic |
Oct, 2020
(3 years ago) | |
Drugs and Companies using ROSIGLITAZONE MALEATE ingredient
Market Authorisation Date: 25 May, 1999
Treatment: Use of avandia as monotherapy, in combination with metformin, and in combination with sulfonylureas to improve glycemic control in patients with type 2 diabetes mellitus; Method of treatment of type i...
Dosage: TABLET
How can I launch a generic of AVANDIA before it's drug patent expiration?
More Information on Dosage
AVANDIA family patents
2. Lovaza patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5502077 | WOODWARD | Fatty acid composition |
Mar, 2013
(11 years ago) | |
| US5656667 | WOODWARD | Fatty acid composition |
Apr, 2017
(7 years ago) | |
| US7732488 | WOODWARD | Pharmaceutical composition comprising low concentrations of environmental pollutants |
Jan, 2025
(6 months from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-87) | Sep 16, 2012 |
Drugs and Companies using OMEGA-3-ACID ETHYL ESTERS ingredient
Market Authorisation Date: 10 November, 2004
Treatment: Use in lipid management
Dosage: CAPSULE
How can I launch a generic of LOVAZA before it's drug patent expiration?
More Information on Dosage
LOVAZA family patents